Since the beginning of the COVID-19 pandemic, telemedicine usage in America has experienced extreme peaks as a method of maintaining social distancing for medical staff and patients. While there have been numerous significant positive effects from increasing this practice, there are also significant risks to be explored. Patients and physicians have been navigating new technology, new protocols, and new dynamics at a high rate. Doctors using telemedicine are required to rely more heavily on their judgment with less data than usual to support their hypotheses. This results in a wide variety of potential complications that can be detrimental to patients and physicians alike. Though negative outcomes are not nearly the majority, it is clear that for telemedicine to function at its fullest capacity, the limitations of its technology must be defined and communicated. A survey was distributed to physicians currently practicing telemedicine to understand more about the usage increase in telemedicine and the incidence rates of telemedicine-related complications. The results showed that although the impact of telemedicine has been largely positive, there certainly are risks that must be considered and prepared for. Thus, it is the responsibility of healthcare systems to ensure that their policies are current and appropriate in proportion to their usage of telemedicine to better protect and prepare patients and doctors for this new frontier of medicine.

This study investigates the impact of the COVID-19 pandemic on telemedicine-prescribed controlled substances by discussing the opinions of pharmacists holding an Arizona pharmacy license. To accommodate the rapid changes during the COVID-19 pandemic, the federal government adapted pharmacy laws to better support the healthcare community. The use of remote healthcare services such as telemedicine visits and online pharmacy services dramatically increased during the pandemic, so regulators waived tele-health restrictions like the Ryan Haight Act. This study involved structured interviews with 3 participants. The interviews revealed a positive outlook on the future of telehealth and the possibilities of modernizing healthcare and pharmacy. The study suggests that the waiving of the Ryan Haight Act was perceived somewhat positively by pharmacists, although they still had concerns regarding abandoning parts of the Act from a patient safety standpoint. The study concludes that certain pharmacy and telemedicine regulations are outdated given the positive and negative outcomes of these laws during the global pandemic. While this study offers insights on bringing various healthcare and law arguments together, the small sample size results in limited scope. The study still provides points of discussion to offer recommendations for implementation of the Ryan Haight Act and other similar tele-health and online-pharmacy regulations.